(Q34572280)

3 August 2017

0 references

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis (English)

1 reference

3 August 2017

0 references

1 reference

2

Valerie Beral

1 reference

PubMed ID

17081916

Million Women Study Collaborators

3 August 2017

series ordinal

6

object named as

Million Women Study Collaborators

1 reference

3 August 2017

4

Toral Gathani

1 reference

3 August 2017

1

Gillian K Reeves

1 reference

3 August 2017

Jane Green

3

1 reference

PubMed ID

17081916

3 August 2017

Diana Bull

series ordinal

5

1 reference

3 August 2017

1 November 2006

1 reference

Lancet Oncology Commission

3 August 2017

1 reference

3 August 2017

7

1 reference

3 August 2017

11

1 reference

3 August 2017

910-918

1 reference

The risk of breast cancer after estrogen and estrogen-progestin replacement

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Hormone replacement therapy in relation to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Established breast cancer risk factors by clinically important tumour characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Breast cancer histological classification: agreement between the Office for National Statistics and the National Health Service Breast Screening Programme

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

Clinical characteristics of different histologic types of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970911-1

7 January 2021

10.1016/S1470-2045(06)70911-1

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

17081916